Does screening or surveillance for primary hepatocellular carcinoma with ultrasonography improve the prognosis of patients?

Cancer Journal

Volumn 10, Issue 5, 2004, Pages 317-325

  Yu, Ernest Wen Ruey ^a,b   Chie, Wei Chu ^a,b   Chen, Tony Hsiu Hsi ^a,b  

^a National Taiwan University ^*

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Hepatocellular carcinoma; Prognosis; Screening; Ultrasonography

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; ADULT; AGED; COMPARATIVE STUDY; FEMALE; HEALTH SURVEY; LIVER TUMOR; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; RISK; SURVIVAL; TAIWAN;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS; TAIWAN;

EID: 16644396568     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200409000-00009     Document Type: Article

References (30)

1. Akriviadis EA, Llovet JM, Efremidis SC et al. Hepatocellular carcinoma. Br J Surg 1998;85:1319-1331.
2. Lu SN, Lee CM, Changchien CS et al. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). Trans R Soc Trop Med Hyg 1999;93:600-602.
3. Cancer Registry Annual Report of the Republic of China 1998. Health Department of the Executive Yuan of the Republic of China, December 2001:34.
4. Sheu JC, Sung JL, Chen DS et al. Early detection of hepatocellular carcinoma by real-time ultrasonography. Cancer 1985;56:660-666.
5. Lai CL, Lau YN, Wu PC et al. Subclinical hepatocellular carcinoma in Hong Kong Chinese. Oncology 1992;49:347-353.
6. Lee CL, Ko YC, Choong CS. Survival rate for liver cancer in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei) 2000;63:16-20.
7. Tang ZY, Yu YQ, Zhou XD et al. Subclinical hepatocellular carcinoma: an analysis of 391 patients. J Surg Oncol 1993;3[suppl]:55-58.
8. Alpert ME, Uriel J, De Nechaud B. Alpha-1 fetoglobulin in the diagnosis of human hepatoma. N Engl J Med 1968;278:984-986.
9. Takashima S, Matsue O, Suzuki M et al. Diagnosis and screening of small hepatocellular carcinomas. Radiology 1982;145:635-638.
10. Paterson D, Ganne N, Trinchet JC et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20:65-71.
11. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432-438.
12. Lok SF, Lai CL. α-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989;9:110-115.
13. McMahon BJ, Bulkow L, Harpster A et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000;32:842-846.
14. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-278.
15. Larcos G, Sorokopud H, Berry G et al. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. Am J Radiol 1998;171:433-435.
16. Poon RT, Ng IO, Fan ST et al. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 2001;19:3037-3044.
17. Solmi L, Primerano AM, Gandolfi L. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases. Am J Gastroenterol 1996;91:1189-1194.
18. Yuen MF, Cheng CC, Lauder IJ et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-335.
19. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998;28:751-755.
20. Vauthey JN, Klimstra D, Blumgan LH. A simplified staging system for hepatocellular carcinomas. Gastroenterology 1995;108:617-618.
21. Okuda K, Ohtsuji T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985;56:918-928.
22. Tsai TJ, Chau GY, Lui WY et al. Clinical significance of microscopic tumor venous invasion in patients with respectable hepatocellular carcinoma. Surgery 2000;127:603-608.
23. Lui WY, Chiu ST, Chiu JH et al. Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma. J Formos Med Assoc 1999;98:248-253.
24. Chen TH, Chen CJ, Yen MF et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002;98:257-261.
25. Lai CL, Gregory PB, Wu PC et al. Hepatocellular carcinoma in Chinese males and females: possible causes for the male predominance. Cancer 1987;60:1107-1110.
26. Lerose R, Molinari R, Rocchi E et al. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer 2001;37:239-245.
27. Zaman SN, Melia WM, Johnson RD et al. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985;1:1357-1360.
28. Tsukuma H, Hiyama T, Tanaka S et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
29. Walter SD, Stitt LW. Evaluating the survival of cancer cases detected by screening. Stat Med 1987;6:885-900.
30. Wong LL, Limn WM, Severino R et al. Improve survival with screening for hepatocellular carcinoma. Liver Transpl 2000;6:320-325